Abstract

Physical and Chemical Stability of Palonosetron Hydrochloride with Lorazepam and Midazolam Hydrochloride during Simulated Y-Site Administration

Author(s): Trissel Lawrence A, Xu Quanyun A

Issue: May/Jun 2005 - Veterinary Compounding

Page(s): 235-237

Download in electronic PDF format for $75
  • Physical and Chemical Stability of Palonosetron Hydrochloride with Lorazepam and Midazolam Hydrochloride during Simulated Y-Site Administration Page 1
  • Physical and Chemical Stability of Palonosetron Hydrochloride with Lorazepam and Midazolam Hydrochloride during Simulated Y-Site Administration Page 2
  • Physical and Chemical Stability of Palonosetron Hydrochloride with Lorazepam and Midazolam Hydrochloride during Simulated Y-Site Administration Page 3

Abstract

The objective of this study was to evaluate the physical and chemical stability of undiluted palonosetron hydrochloride 50 µg/mL in combination with lorazepam 0.5 mg/mL or midazolam hydrochloride 2 mg/mL in 5% dextrose injection during simulated Y-site administration. Triplicate test samples were prepared by admixing 5 mL of palonosetron hydrochloride with 5 mL of the lorazepam or midazolam hydrochloride admixture. Physical stability was assessed by using a multistep evaluation procedure that included both turbidimetric and particulate measurements as well as visual inspection. Chemical stability was assessed by using stability-indicating high-performance liquid chromatographic analytical techniques that determined drug concentrations. Evaluations were performed initially upon mixing and again 1 and 4 hours after mixing. The samples were clear and colorless when viewed in normal fluorescent room light and when viewed with a Tyndall beam. Measured turbidity remained unchanged; particulate content was low and changed little. High-performance liquid chromatographic analysis revealed that palonosetron hydrochloride, lorazepam, and midazolam hydrochloride remained stable throughout the 4-hour test with no drug loss. Palonosetron hydrochloride is physically compatible and chemically stable with lorazepam or midazolam hydrochloride during Y-site administration.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy
Title/Author
(Click for Abstract / Details / Purchase)
May/Jun 2005
Pg. 235-237
Mar/Apr 2008
Pg. 170-173
Mar/Apr 2008
Pg. 156-160
Jul/Aug 2008
Pg. 368-371
May/Jun 2005
Pg. 238-241
Nov/Dec 2007
Pg. 520-524
Jan/Feb 2009
Pg. 78-80
Sep/Oct 2008
Pg. 460-462
Jul/Aug 2005
Pg. 320-322
Jan/Feb 2007
Pg. 82-85
Jan/Feb 2017
Pg. 76-82
May/Jun 2006
Pg. 234-236
May/Jun 1999
Pg. 235-238
Jan/Feb 2018
Pg. 76-85
Jan/Feb 1998
Pg. 79-82
Jan/Feb 2002
Pg. 66-69
Jan/Feb 2002
Pg. 70-73
Sep/Oct 2013
Pg. 436-438
Jan/Feb 2018
Pg. 86-94
Jul/Aug 1998
Pg. 318-321